AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $38.92M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| OSL | Ann: 120 German Hospitals entitled to negotiate fee for OncoSil | 04/02/25 | 0 | 1 | |||
|
|||||||
| OSL | Ann: OncoSil Medical raises $4.0m from Share Purchase Plan | 22/04/18 | 4 | 1.2K | |||
|
|||||||
| OSL | Ann: Appendix 3B - Share Purchase Plan | 20/04/18 | 0 | 132 | |||
|
|||||||
| OSL | Ann: ASIC Form 484 | 20/04/18 | 0 | 138 | |||
|
|||||||
| OSL | Ann: Presentation-Surgical Resection Outcomes and Capital Raising | 16/04/18 | 46 | 14K | |||
|
|||||||
| OSL | Ann: EGM Notice of Meeting & Proxy Form | 13/04/18 | 0 | 190 | |||
|
|||||||
| OSL | Ann: Oncosil Medical Share Purchase Plan Closing Date Reminder | 11/04/18 | 0 | 207 | |||
|
|||||||
| OSL | Ann: Oncosil Medical presents at Proactive Investors CEO Sessions | 09/04/18 | 0 | 170 | |||
|
|||||||
See All Discussions
ASX News